These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 33784302)
41. Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni. Lombardo FC; Pasche V; Panic G; Endriss Y; Keiser J Nat Protoc; 2019 Feb; 14(2):461-481. PubMed ID: 30610241 [TBL] [Abstract][Full Text] [Related]
42. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy. Buchter V; Hess J; Gasser G; Keiser J Parasit Vectors; 2018 Nov; 11(1):580. PubMed ID: 30400935 [TBL] [Abstract][Full Text] [Related]
43. Early Antischistosomal Leads Identified from in Vitro and in Vivo Screening of the Medicines for Malaria Venture Pathogen Box. Pasche V; Laleu B; Keiser J ACS Infect Dis; 2019 Jan; 5(1):102-110. PubMed ID: 30398059 [TBL] [Abstract][Full Text] [Related]
44. Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni. Pasche V; Laleu B; Keiser J Parasit Vectors; 2018 May; 11(1):298. PubMed ID: 29764454 [TBL] [Abstract][Full Text] [Related]
45. Antischistosomal agents: state of art and perspectives. Lago EM; Xavier RP; Teixeira TR; Silva LM; da Silva Filho AA; de Moraes J Future Med Chem; 2018 Jan; 10(1):89-120. PubMed ID: 29235368 [TBL] [Abstract][Full Text] [Related]
46. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium. Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009 [TBL] [Abstract][Full Text] [Related]
47. Real-time PCR for sexing Schistosoma mansoni cercariae. Chevalier FD; Le Clec'h W; Alves de Mattos AC; LoVerde PT; Anderson TJ Mol Biochem Parasitol; 2016; 205(1-2):35-8. PubMed ID: 27021570 [TBL] [Abstract][Full Text] [Related]
48. Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni. Panic G; Vargas M; Scandale I; Keiser J PLoS Negl Trop Dis; 2015; 9(7):e0003962. PubMed ID: 26230921 [TBL] [Abstract][Full Text] [Related]
53. Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies. Xiao SH Parasitol Res; 2013 Nov; 112(11):3723-40. PubMed ID: 23979493 [TBL] [Abstract][Full Text] [Related]
60. Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo. Manneck T; Braissant O; Ellis W; Keiser J Exp Parasitol; 2011 Jan; 127(1):260-9. PubMed ID: 20732321 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]